GlucoTrack, Inc.

NASDAQ (USD): GlucoTrack, Inc. (GCTK)

Last Price

0.139

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Profile
GCTK

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Paul V. Goode Ph.D. Mr. Paul V. Goode Ph.D.

Full Time Employees:  6 6

IPO Date:  2013-04-25 2013-04-25

CIK:  0001506983 0001506983

ISIN:  US45824Q5071 US45824Q5071

CUSIP:  45824Q507 45824Q507

Beta:  0.16 0.16

Last Dividend:  0.00 0.00

Dcf Diff:  -0.66 -0.66

Dcf:  1.03 1.03

Description

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Address

8 Ariel Sharon Street,
Or Yehuda, 7760049, IL

972 8 675 7878

http://www.glucotrack.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment